Matches in Wikidata for { <http://www.wikidata.org/entity/Q46107820> ?p ?o ?g. }
- Q46107820 description "2017 nî lūn-bûn" @default.
- Q46107820 description "2017 թվականի հոկտեմբերի 4-ին հրատարակված գիտական հոդված" @default.
- Q46107820 description "2017年の論文" @default.
- Q46107820 description "2017年学术文章" @default.
- Q46107820 description "2017年学术文章" @default.
- Q46107820 description "2017年学术文章" @default.
- Q46107820 description "2017年学术文章" @default.
- Q46107820 description "2017年学术文章" @default.
- Q46107820 description "2017年学术文章" @default.
- Q46107820 description "2017年學術文章" @default.
- Q46107820 description "2017年學術文章" @default.
- Q46107820 description "2017年學術文章" @default.
- Q46107820 description "2017年學術文章" @default.
- Q46107820 description "2017年學術文章" @default.
- Q46107820 description "2017년 논문" @default.
- Q46107820 description "article científic" @default.
- Q46107820 description "article scientific" @default.
- Q46107820 description "article scientifique" @default.
- Q46107820 description "articol științific" @default.
- Q46107820 description "articolo scientifico" @default.
- Q46107820 description "artigo científico" @default.
- Q46107820 description "artigo científico" @default.
- Q46107820 description "artigo científico" @default.
- Q46107820 description "artikel ilmiah" @default.
- Q46107820 description "artikull shkencor" @default.
- Q46107820 description "artikulong pang-agham" @default.
- Q46107820 description "artykuł naukowy" @default.
- Q46107820 description "artículo científico publicado en 2017" @default.
- Q46107820 description "artículu científicu" @default.
- Q46107820 description "bilimsel makale" @default.
- Q46107820 description "bài báo khoa học" @default.
- Q46107820 description "naučni članak" @default.
- Q46107820 description "scienca artikolo" @default.
- Q46107820 description "scientific article published on 4 October 2017" @default.
- Q46107820 description "scientific article published on 4 October 2017" @default.
- Q46107820 description "scientific article published on 4 October 2017" @default.
- Q46107820 description "teaduslik artikkel" @default.
- Q46107820 description "tieteellinen artikkeli" @default.
- Q46107820 description "tudományos cikk" @default.
- Q46107820 description "vedecký článok" @default.
- Q46107820 description "vetenskaplig artikel" @default.
- Q46107820 description "videnskabelig artikel" @default.
- Q46107820 description "vitenskapelig artikkel" @default.
- Q46107820 description "vitskapeleg artikkel" @default.
- Q46107820 description "vědecký článek" @default.
- Q46107820 description "wetenschappelijk artikel" @default.
- Q46107820 description "wissenschaftlicher Artikel" @default.
- Q46107820 description "επιστημονικό άρθρο" @default.
- Q46107820 description "мақолаи илмӣ" @default.
- Q46107820 description "наукова стаття, опублікована в жовтні 2017" @default.
- Q46107820 description "научна статия" @default.
- Q46107820 description "научная статья" @default.
- Q46107820 description "научни чланак" @default.
- Q46107820 description "научни чланак" @default.
- Q46107820 description "מאמר מדעי" @default.
- Q46107820 description "مقالة علمية نشرت في 4 أكتوبر 2017" @default.
- Q46107820 description "৪ অক্টোবর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46107820 description "บทความทางวิทยาศาสตร์" @default.
- Q46107820 description "სამეცნიერო სტატია" @default.
- Q46107820 name "Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (" @default.
- Q46107820 name "Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (" @default.
- Q46107820 type Item @default.
- Q46107820 label "Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (" @default.
- Q46107820 label "Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (" @default.
- Q46107820 prefLabel "Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (" @default.
- Q46107820 prefLabel "Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (" @default.
- Q46107820 P1433 Q46107820-3540CE0D-7995-4396-94BD-DBE27048183B @default.
- Q46107820 P1476 Q46107820-4FE6C132-DBEE-42E7-8881-157DD673C2EF @default.
- Q46107820 P2093 Q46107820-2389ABB8-92E4-4132-ACD8-9528E7F3131E @default.
- Q46107820 P2093 Q46107820-753A1D84-5A71-4E3C-B514-E4B602E671C4 @default.
- Q46107820 P2093 Q46107820-8891C154-7899-49D8-B0C0-2AEBB20B5BCD @default.
- Q46107820 P2093 Q46107820-BD3FFBB6-0BB5-4C72-ADDD-65E118A5E130 @default.
- Q46107820 P2093 Q46107820-C82C0A90-EF63-48F9-B459-28C2656CB686 @default.
- Q46107820 P2093 Q46107820-F82AF81A-B13A-459F-8280-CEE304DEB13D @default.
- Q46107820 P275 Q46107820-7e5620f0-4b5c-47e7-b7fc-1e3e3bb9dc22 @default.
- Q46107820 P304 Q46107820-34D4E6FF-E222-4622-A801-4F3C24A79768 @default.
- Q46107820 P31 Q46107820-4723BB16-0A9F-4BD8-807D-96CF695B6354 @default.
- Q46107820 P356 Q46107820-8726B375-9ABC-42EC-9D03-1D303A252895 @default.
- Q46107820 P433 Q46107820-461B593D-0074-4D82-8F22-EFA99302BBE2 @default.
- Q46107820 P478 Q46107820-2DB6A357-7853-4ED0-BEB1-82CEDD179AF8 @default.
- Q46107820 P50 Q46107820-4F8A092C-9BF6-462E-B392-E852C575183E @default.
- Q46107820 P50 Q46107820-8C363AC0-93F7-414A-B0BB-C2ACD418305D @default.
- Q46107820 P50 Q46107820-9A21C7FB-81AF-4FB6-9144-A52889819379 @default.
- Q46107820 P50 Q46107820-9E3098EC-6062-476F-BCFE-FAC07397D288 @default.
- Q46107820 P50 Q46107820-A58EC66F-FF4D-4F48-93BF-A2D306D443A5 @default.
- Q46107820 P577 Q46107820-0E645E9D-7F09-43E0-ACF4-DB68AA20E247 @default.
- Q46107820 P6216 Q46107820-35d2b73d-defe-4b59-bd84-277b83e80be9 @default.
- Q46107820 P921 Q46107820-0B54373A-CAF1-4B60-A072-FA5698AA011C @default.
- Q46107820 P921 Q46107820-C4E70174-1B47-43F3-92F3-F044F1B85A8D @default.
- Q46107820 P932 Q46107820-AD8BF25E-3343-490C-A2A2-B9DE1DB211EB @default.
- Q46107820 P356 OFX180.009 @default.
- Q46107820 P1433 Q27725953 @default.
- Q46107820 P1476 "Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (QD), Single-tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed, HIV-1-infected Adults" @default.
- Q46107820 P2093 "Erika Van Landuyt" @default.
- Q46107820 P2093 "Erkki Lathouwers" @default.
- Q46107820 P2093 "Joel Gallant" @default.
- Q46107820 P2093 "Magda Opsomer" @default.
- Q46107820 P2093 "Romana Petrovic" @default.
- Q46107820 P2093 "Veerle Hufkens" @default.
- Q46107820 P275 Q24082749 @default.